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Abstract
Coastal El Niño is a weather phenomenon that is caused by abnormal warming 
(above 0.4°C) of the Pacific Ocean waters near the coasts of Ecuador and Peru, and 
it can even reach the central and southern Peruvian coast. As a result of the climatic 
phenomenon, the Aedes aegypti vector (which in turn is a vector of chikungunya 
and Zika fever) had been quickly installed in 448 districts of Peru, and emergency 
was declared in 10 regions, which reported 231,874 victims; 1,129,013 affected and 
143 dead. It is necessary to know this, because the direct impact of the weather phe-
nomena contributes to the dengue vector conditioning, facilitating its dissemina-
tion with ease. The geographical and climatic conditions of the cities most affected 
by the El Niño Costero phenomenon turned them into zones of epidemics; in these 
places, there is an important population growth, from urbanization to sectorization 
in young towns and urban slums, where in many there is no basic infrastructure 
and water supply is insufficient, which requires temporary water storage, as well as 
high temperatures, migratory movement, and beaches with influx of people, which 
make not only dengue proliferate but also other arbovirosis such as chikungunya.
Keywords: dengue, natural phenomenon, natural disaster, public health
1.  Epidemiology of dengue and the coastal El Niño phenomenon in Peru 
and Ecuador
1.1 Epidemiological data
Coastal El Niño is a weather phenomenon that is caused by abnormal warming 
(above 0.4°C) of the Pacific Ocean waters near the coasts of Ecuador and Peru, and 
it can even reach the central and southern Peruvian coasts. As a result, it produces 
intense rains that, in turn, cause overflow of streams, floods, and allow the accu-
mulation of stagnant waters, which forms the ideal scenario for the appearance of 
outbreaks of vector-borne diseases such as dengue (DENV), other arbovirosis, and 
zoonotics such as leptospirosis [1–4]. This phenomenon was presented more clearly 
in the summer of 2017; however, rains and floods have been reported for Peru even 
since December 2016 [5].
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As a result of the climatic phenomenon, the Aedes aegypti vector (which in turn 
is a vector of chikungunya and Zika [ZIKV] fever) had been quickly installed in 
448 districts of Peru, where more than 14 million people live, by July 2017 [6]. 
Thus, the Peruvian State in June 2017, declared emergency in 10 regions, which 
reported 231,874 victims; 1,129,013 affected and 143 dead. It is necessary to know 
this, because the direct impact of the weather phenomena contributes to the dengue 
vector conditioning, facilitating its dissemination with ease. Thus, the Peruvian 
Ministry of Health reported that at the end of 2017, the epidemiological surveil-
lance system reported 76,093 cases of dengue (among probable and confirmed), 
marking an increase of up to three times more cases compared to 2016 (25,236 
cases) (Figure 1) [7].
Among the most frequently reported forms were dengue without warning signs 
(88.6%), dengue with warning signs (11%), and severe dengue (0.3%). The cumu-
lative national incidence for 2017 was 239.1 cases per 100,000 inhabitants and there 
were 93 deaths, of which 79 were confirmed cases and 14 were probable [8].
There was a marked increase in cases, in those places where there was a greater 
presence of rain and floods. Thus, for example, Piura concentrated 64% of dengue 
cases: this place being one of the most affected cities and even presented an over-
flow from its main river that crosses through the same city, the river Piura [9].
Do not forget that northern Peru is an endemic area due to climate, geography, 
and other factors that make it a vector-friendly ecosystem, being considered one of 
the countries with the greatest impact due to climate change [10].
1.2 Dengue and climate
Dengue transmission occurs through an insect vector, predominantly Aedes 
aegytpi but also Aedes albopictus. Environmental parameters, especially temperature 
and precipitation, affect the demography and behavior of these vectors, making 
dengue an obvious candidate to investigate the impact of climate on the disease. The 
incidence of dengue is very seasonal; this seasonality is the footprint of local meteo-
rological variables, which also vary seasonally, and their impact on the demograph-
ics of mosquito vectors and transmission dynamics [11].
Figure 1. 
Number of dengue cases, according to epidemiological weeks. Peru, 2013–2017. Taken from: Ministry of Health 
of Peru MINSA [12].
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The geographical and climatic conditions of the cities most affected by the El 
Niño Costero phenomenon turned them into zones of epidemics; in these places, 
there is an important population growth, from urbanization to sectorization in 
young towns, urban slums, where in many there is no basic infrastructure and water 
supply is insufficient, which requires temporary water storage, as well as high tem-
peratures, migratory movement, and beaches with influx of people, which make 
not only dengue proliferate but also other arbovirosis such as chikungunya [13].
1.3 Epidemiology of other metaxenic diseases
The propagation of the vector for decades is conditioned by the climatic 
changes. For example, in May 2004, heat waves and droughts were observed in 
the coastal areas of Kenya, toward Lamu and Mombasa, two large coastal cities. 
That period was also the beginning of a large chikungunya outbreak in these two 
cities (with reported attack rates of 75%) before its spread to the Indian Ocean 
[14]. Entomologists have explained how and why droughts can be associated with 
increases in diseases transmitted by Aedes, such as chikungunya, dengue, Zika, and 
yellow fever [15, 16]. During droughts, due to water scarcity, people store a greater 
amount of water outside or inside the home for longer periods of time, providing 
shelters to mosquito eggs and larvae [13].
In Peru, the consequence of this weather phenomenon allowed the dissemina-
tion of the Aedes vector and consequently led to the increase in cases of emerging 
diseases, such as Zika and chikungunya (Figure 2). Thus, from 2016 to 2018, 1113 
gestating women entered the surveillance system for Zika, of which 61% were noti-
fied in 2017. Of the total number of pregnant women notified, 31% had laboratory 
confirmation for Zika virus through molecular tests like polymerase chain reaction-
reverse transcription (RT-PCR) [7].
1.4 Dengue and coinfections
The fluvial precipitations that the phenomenon of the coastal El Niño brought 
with it during 2017 triggered the collapse of the sewerage system, generating floods 
and the exposure of wastewater, which together with the rains gave an adequate 
Figure 2. 
Distribution of indigenous cases of Zika by onset of symptoms. Peru 2016–2017. Taken from: Ministry of Health 
of Peru MINSA [17].
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environment for the transmission of leptospirosis in urban areas of the Lambayeque 
region. It was even possible to demonstrate that during this period, laboratory 
findings compatible with dengue and leptospirosis were reported simultaneously. 
While it is true that many of the immunoglobulin can remain for years in the patient 
and do not necessarily require an acute infection, the similarity of clinical symp-
toms between dengue and leptospirosis makes both pathologies confusing to health 
personnel, even more so during the appearance of a weather phenomenon where 
there is an outbreak [18].
1.5 Dengue and seasonality
Dengue in Ecuador fluctuates with a very similar seasonality. The season is an 
important determinant of infectious disease rates, including mosquito-propagated 
arboviruses, such as dengue, chikungunya, and Zika. Seasonal disease patterns are 
driven by a combination of climatic or environmental factors, such as temperature or 
rainfall, and trends in human behavior time, such as school year schedules, vacations, 
and weekend patterns. These factors affect both disease rates and medical care-
seeking behavior. The seasonality of dengue fever has been studied in the context 
of climatic factors. Thus, between 2009 and 2016, a predictive model of dengue 
detection was studied using data from the same patients in rural areas in Ecuador. 
Thus, compared to the average of every day, cases were more likely to be diagnosed 
on Tuesdays (relative risk [RR]: 1.26; 95% confidence interval [CI]: 1.05–1.51) and 
Thursdays (RR: 1.25; 95% CI: 1.02–1.53), and were less likely to be diagnosed on 
Saturdays (RR: 0.81; 95% CI: 0.65–1.01) and Sundays (RR: 0.74; 95% CI: 0.58–0.95). 
The holidays were not significant predictors of dengue diagnoses, except for an 
increase in diagnoses the day after Christmas (RR: 2.77; 95% CI: 1.46–5.24) [19].
From the political sphere, the coastal El Niño phenomenon caused the Ministry 
of Health and the Ministry of Defense of Ecuador to take into account the declara-
tion of emergency for the Peruvian city of Piura, issued by the Ministry of Health 
of that country. This is because that city is close to the border of Ecuador, and the 
trade between the two countries is very high, which makes it necessary to work in a 
multisectoral way to eradicate the vector [20].
1.6 Impact on the epidemiological surveillance system
It is very necessary to maintain entomological surveillance, especially in those 
cities where the phenomenon left vector presence. Migration and population 
increase, in addition to raising awareness and educating the population about the 
risk factors of dengue occurrence, should always be taken into account to avoid a 
disease that was installed in the Americas decades ago, precisely because of migra-
tion from other areas. The consequences of climate change must be learned as it 
not only destroys our habitat but directly interferes with our health [21]. Health 
authorities have the responsibility to plan strategies and evaluate their impact 
progressively. Many times it is not enough to plan, but to change strategies to avoid 
having the same results.
2. Clinical behavior of dengue
2.1 Definitions
Classically, the disease presents with an incubation period of 3–14 days; after 
that a febrile phase (1–4 days); viremia, the critical phase from 4 to 7 days; and a 
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recovery phase from day 7 onward [22]. This disease course depends on the virus 
serotype and whether or not the individual has previously had a dengue infection. 
In this spectrum of disease, one can have:
• Dengue without warning signs: Person with a fever of 7 or less days, with at 
least two of the following symptoms such as eye pain, myalgia, headache, 
arthralgia, low back pain, rash, and nausea [23, 24].
• Dengue with warning signs: Person with a probable case of dengue with one 
or more of the clinical signs such as severe abdominal pain, dyspnea, serous 
effusion, persistent vomiting, hypothermia, mucosal bleeding, altered mental 
status, increased hematocrit, and hepatomegaly [23, 24].
• Severe dengue: A probable case with or without warning signs presenting one 
of the following signs such as signs of hypovolemic shock, severe bleeding, 
respiratory distress syndrome due to plasma extravasation, and severe organ 
involvement (encephalitis, hepatitis, and myocarditis) [25].
2.2 Signs and symptoms
It is known that the cross-immunity of dengue serotypes is limited, which increases 
the possibility of reinfections and with them more florid clinical pictures [25, 26].
Previous studies observed the outbreaks from 2010 onward, observing that 
dengue cases occurred in a greater proportion due to DENV-2, the most frequent 
clinical symptom being retro-ocular pain, myalgias associated with a 7-day fever 
[27]. Also, it was observed that in dengue cases, many of them were reinfections 
and DENV-2 continued to prevail, which was one of the worst at presenting cross-
immunity (Figure 3).
A study conducted in the north coast of Peru found that, among the referred 
symptoms, 82% reported fever, being less than half quantified (values from 37to 
41°C), followed by headache (75.6%), arthralgias (69.7%), myalgias (62.4%), 
retroocular pain (55.5%), lumbar pain (44.7%), and only 24.4% presenting rash. 
The presence of platelet decrease (78.4%) was the most frequent among cases with 
alarm signs [28] (Figure 4).
Figure 3. 
Age distribution of DENV-neutralizing antibodies in 2010. Samples were collected between March and June 
2010, approximately 6 months prior to a large dengue epidemic largely caused by American/Asian genotype 
DENV-2. Panel A: Age distribution of serotype-specific DENV-neutralizing antibodies. Panel B: Age 
distribution of number of prior DENV infections. Naive indicates absence of detectable DENV-neutralizing 
antibodies against any serotype, monotypic indicates DENV-neutralizing antibodies against one serotype, 
and multitypic indicates DENV-neutralizing antibodies against two or more serotypes. Taken from: Forshey 
et al. [29].
Please use Adobe Acrobat Reader t  read this book chapter for free.
Just open this sam  document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
Securing Connection...Acrobat is locking documen loading.com
r
File cannot be found.
Dengue Fever in a One Health Perspective
6
2.3 Signs and symptoms in coinfections
In recent years, new viruses such as chikungunya (CHIKV) and Zika (ZIKV) have 
also been introduced. In recent years after the ZIKV epidemic, cases of ZIKV infection 
have continued to be observed, and in children, according to Salgado et al. [30], there 
were found patients with encephalitis with coinfection of DENV and ZIKV.
Another study, also conducted in Peru, showed that the circulating serotypes 
during the coastal El Niño phenomenon were DENV-2 and DENV-3, as well as 
confirmed cases of CHIKV and ZIKV, even in high Andean areas; concomitantly, 
the study revealed that the main symptoms of dengue were headaches, arthralgias, 
and back pain associated with fever (Table 1) [27].
Taken from: Forshey et al. [29].
In Peru, there could be a subdiagnosis or overdiagnosis of dengue and therefore 
of the clinical variability, on the one hand; the amount of arbovirosis that can give 
a similar clinical presentation is wide, and within these viruses is oropuche, which 
can be confused with dengue during the endemic months [31]. The contrary occurs 
in patients with a second dengue virus infection in which the diagnostic methods 
have a lower sensitivity of 60%, as is the case of non-structural (NS1), a test widely 
used in our environment [26].
The Huánuco region, located in the center of Peru, was one of the cities that 
presented an increase in dengue cases, where about 90% of patients presented with 
myalgia, headache, and rash; being in these patients a diagnostic confirmation of 
92% by PCR. This being an area with low endemicity, but as a result of coastal El 
Niño, it could mean a majority of primary infection, and therefore this high rate of 
clinical diagnostic correlation [26]. In addition, it is important to know the behavior 
in children under 5 years of age, in which many of them have antigens from mothers 
in endemic areas, which leads to more severe manifestations being possible in this 
particular age group [32].
Finally, it can be observed that, in the years before the dengue virus infection, 
the agent (DENV-2) and the clinical manifestations were similar, with the differ-
ence in the number of cases and the increase in coinfections of the new circulating 
Figure 4. 
Symptomatology of patients diagnosed with dengue. (A) Symptoms and signs. (B) Warning signs. Taken from: 
Perales-Carrasco et al. [28].
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viruses; this should make the health staff reflect on making proper use of diagnostic 
tests to provide better care and avoid fatal outcomes, as it was in some cases dis-
cussed above in the last phenomenon of the coastal El Niño (Table 2).
3. Laboratory in the diagnosis of dengue
Today, there are guidelines established by international organizations for the 
rational use of dengue diagnostic tests. The World Health Organization (WHO) 
recommends the use of polymerase chain reaction (PCR) for the early detection of 
dengue and its complementation with other tests such as immunoglobulin M (IgM), 
immunoglobulin G (IgG), and NS1 [33]; however, the use according to the clinical 
picture and the time of the disease will favor the optimal use of the different tests.
The sensitivity and specificity of the NS1 antigen test can range from 49 to 59% 
and from 93 to 99%, respectively, while that of the IgM antibody test is from 71 to 
Clinical symptoms Total n = 496 (%) PCR real-time confirmed cases
DENV 
(n = 170)
ZIKV 
(n = 39)
CHIKV 
(n = 23)
n (%) n (%) n (%)
Chills 3 (0.6) 1 (0.6) 0 (0.0) 0 (0.0)
Headache 444 (89.5) 152 (89.4) 34 (87.2) 20 (87.0)
Dizziness 1 (0.2) 0 (0.0) 1 (2.6) 0 (0.0)
Cough 1 (0.2) 1 (0.6) 0 (0.0) 0 (0.0)
Sore throat 184 (37.1) 50 (29.4) 11 (28.2) 11 (47.8)
Nausea and/or vomits 251 (50.6) 86 (50.6) 20 (51.3) 13 (56.5)
Loss of appetite 312 (62.9) 104 (61.2) 23 (59.0) 18 (78.3)
Back pain 270 (54.4) 105 (61.8) 23 (59.0) 17 (73.9)
Dysuria 1 (0.2) 0 (0.0) 0 (0.0) 0 (0.0)
Myalgia 419 (84.5) 147 (86.5) 35 (89.7) 17 (73.9)
Arthralgia 396 (79.8) 143 (84.1) 32 (82.1) 19 (82.6)
Retro-ocular pain 337 (67.9) 118 (69.4) 27 (69.2) 17 (73.9)
Rash 89 (17.9) 26 (15.3) 8 (20.5) 6 (26.1)
Melena 2 (0.4) 0 (0.0) 0 (0.0) 0 (0.0)
Nasal bleeding 9 (1.8) 3 (1.8) 1 (2.6) 1 (4.3)
Gums bleeding 3 (0.6) 2 (1.2) 1 (2.6) 0 (0.0)
Petechiae 11 (2.2) 3 (1.8) 0 (0.0) 1 (4.3)
Ecchymosis 2 (0.4) 1 (0.6) 1 (2.6) 0 (0.0)
Blood-tinged sputum 1 (0.2) 0 (0.0) 0 (0.0) 0 (0.0)
Abdominal pain 22 (4.4) 7 (4.1) 1 (2.6) 1 (4.3)
Thoracic pain 5 (1.0) 2 (1.2) 0 (0.0) 0 (0.0)
Fatigue 3 (0.6) 0 (0.0) 1 (2.6) 0 (0.0)
Altered mental status 1 (0.2) 1 (0.6) 0 (0.0) 1 (4.3)
Table 1. 
Clinical symptoms in patients with positive samples for DENV, ZIKV, and CHIKV.
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80% and 46 to 90%, respectively, considering a median of 5 days of fever before 
the collection of the samples (interquartile range of 3–7 days) for the two tests 
mentioned. The diagnostic accuracy for the detection of IgM increases for late acute 
infection (5 days after the onset of symptoms) compared to the early one. The NS1 
antigen is an early marker of acute infection, and its combined use with IgM detec-
tion can provide a definitive diagnosis of 96.9–100% for samples obtained after 3 
days of illness [33]. The reported sensitivity and specificity of IgG for dengue are 
92.0 and 100%, respectively [34].
The patient usually has an incubation period of 4–5 days after the bite by mos-
quitoes of the Aedes genus, then presents a clinical picture with variable signs and 
symptoms for a period of 4–5 days, a period in which he presents the virus of the 
dengue circulating in the bloodstream and can transmit the disease to other patients 
through new bites by the aforementioned vector, so techniques based on virus isola-
tion, through cultures, or the detection of genomic material, such as PCR, require 
samples taken during this time. The end of the patient’s clinical picture is usually 
manifested by a generalized maculopapular rash, which indicates recovery and can 
guide the use of serological tests, such as the detection of IgM and IgM antibodies, 
since the viral load values in the patient have disappeared or significantly reduced, 
which would make the use of molecular tests or culture inefficient. Leukopenia can 
be found at this stage with normal platelet and transaminase counts [3].
Characteristics Crude analysis Risks for dengue
Chikungunya Dengue p-value Adjusted odds ratio 
(95% CI)*
Clinical
Diarrhea, n (%) 3/37 (8) 13/57 (23) 0.064 2.13 (0.29–15.66)
Ascites, n (%) 0/37 (0) 1/57 (2) 1.000** N.E.
Pleural effusion, n (%) 0/37 (0) 2/56 (4) 0.516 N.E.
Laboratory
Hemoglobin (mg/dl) median
(interquartile range 
(IQR)) [n]
10.5 (10–12) [35] 10.5 (10–12) 
[36]
0.910
Decrease for age, n (%) 26/36 (72) 25/53 (47) 0.019 1.33 (0.26–6.87)
Increase for age, n (%) 0/36 (0) 1/53 (2) 1.000** N.E.
Hematocrit (%) median 
(IQR) [n]
30.9 (29–34) [33] 31.5 (30–35) 
[37]
a. 0.510
Decrease for age, n (%) 24/33 (73) 30/52 (58) 0.160 1.04 (0.26–4.19)
Increase for age, n (%) 0/33 (0) 1/52 (2) 1.000** N.E.
White blood cells (1000 
cells/ml)
Median (IQR) [n]
6.4 (5–10) [33] 7.4 (5–12) 
[36]
0.220
Decrease for age, n (%) 17/33 (52) 16/53 (30) 0.048 0.28 (0.07–1.08)
Increase for age, n (%) 4/33 (12) 5/53 (9) 0.728 1.97 (0.27–14.17)
Note: N.E.: Not estimable. Taken from: Paternina-Caicedo et al. [32].
*Adjusted by age, days with symptoms, and sex.
**Fisher’s exact test.
***Best fit was the natural logarithm of the exposure variable.
Table 2. 
Clinical and laboratory characteristics of chikungunya and dengue and their relative adjusted risks among 
children <24 months of age in Colombia.
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We can summarize the diagnostic tests used for dengue in four groups: (i) virus 
isolation and characterization, (ii) detection of the genomic sequence through a 
nucleic acid amplification test, (iii) detection of specific antibodies against the 
virus, and (iv) identification of dengue virus (glycoprotein) antigens. Isolation of 
the virus is achieved by cell culture that gives the most specific result, and the sera 
are usually collected in the first 3–5 days after the fever starts. Virus isolation is 
highly dependent on viral load, which limits the period during which the virus can 
be successfully isolated in the patient’s serum. In addition, its high cost makes this 
test little accessible to most laboratories [3]. Viral identification can also be done 
using dengue-specific monoclonal antibodies by immunofluorescence and reverse 
transcription-PCR (RT-PCR) [3].
On the other hand, serological tests are relatively inexpensive and easy to 
perform. These characteristics make them the most used tests for dengue infection. 
IgM levels begin to rise on the third day of a primary infection and peak at 2 weeks 
after the onset of fever (Figure 5). IgG is detectable at the end of the first week of 
illness and may persist for life. Enzyme-linked immunosorbent assay (ELISA) tests 
can analyze the levels of IgM and IgG, and the IgM/IgG ratio is useful to distinguish 
primary from secondary infections. The IgM/IgG ratio greater than 1.4 is indicative 
of primary dengue infection, while the IgM/IgG ratio lesser than 1.2 is indicative 
of secondary dengue infection. The potential cross-reactivity of dengue virus with 
other flaviviridae when using serological assays remains a significant limitation for 
its use. Prior vaccination against yellow fever can also lead to a false positive sero-
logical test for dengue virus. The prolonged period of seroconversion also results in 
false negatives [3]. All flaviviruses produce a glycoprotein called NS1 and tests such 
as antigen capture ELISA and quick tests based on immunochromatography can 
be used to identify it in the bloodstream; it is detectable from days 0 to 9 after the 
onset of symptoms, although detection appears to be higher in the samples collected 
up to 3 days after the onset of symptoms. Quick tests are now available and provide 
results in 15 min. Rapid tests for NS1 have been estimated to have a significantly 
higher sensitivity for primary infections (94.7%) than for secondary infections 
(67.1%; p < 0.001) and now appear to be a potential alternative to culture, PCR, and 
serology [38].
The Brazilian Ministry of Health recommends that samples of patients with 
suspected dengue fever taken up to 8 days (preferably 5) after the onset of symp-
toms should be processed using ELISA for the detection of NS1 and qRT PCR for 
the detection of the DENV genome and the serotype. At 8–15 days after the onset of 
symptoms, the samples are analyzed for IgM detection using ELISA. After 15 days, 
Figure 5. 
(A) Primary infection by dengue. (B) Secondary infection by dengue. Source: Clinical Pathology Department, 
Almanzor Aguinaga Asenjo, Hospital, Essalud.
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the sera are selected for IgG using ELISA. Dengue infection cannot be excluded in 
samples that are negative for the NS1 antigen and must be confirmed by IgM/IgG 
detection [35].
Cases of DENV-2 had a higher proportion of severe dengue than among those of 
DENV-1 and DENV-4 [39]. Nevertheless, the secondary infection was not a predic-
tor of severe clinical manifestation in adults, who were primarily infected with 
serotype DENV-3 [40]; on the other hand, the dengue in children have suggested 
that infection with secondary DENV-2 is more likely to result in severe disease 
compared with other serotypes [41].
The fifth variant DENV-5 has been isolated in October 2013. This serotype 
follows the sylvatic cycle unlike the other four serotypes which follow the human 
cycle. The likely cause of emergence of the new serotype could be genetic recombi-
nation, natural selection, and genetic bottlenecks [42].
4.  Diagnosis of dengue and other arbovirosis in the context of the 
Guillain Barre syndrome epidemic
During the months of June–July of 2019, 35 cases were registered and diag-
nosed as the Guillain-Barre Syndrome, at the Almanzor Aguinaga Asenjo National 
Hospital of Chiclayo in Peru, of which 22 had electrophysiology results compatible 
with the said syndrome, two had a normal result, and 11 were not evaluated with 
the mentioned diagnostic test. Three cases had IgG for flavivirus, three cases had 
IgG for flavivirus and IgG for chikungunya concomitantly, four cases had IgG for 
chikungunya, and one case had IgM for chikungunya. In other words, there were 
11 cases of patients with a history of flavivirus or chikungunya infections in the 
context of the presentation of Guillain-Barre syndrome [43]. These patients were 
evaluated with the recomLine Tropical Fever IgG and IgM tests, immunoblot of 
German origin that has a sensitivity for IgG of 100% for primary infection by Zika, 
100% for secondary infection for dengue or Zika, and 98.6% for primary infec-
tion by dengue; also the IgM has a sensitivity of 72.7% for dengue or Zika, and 
both tests have a specificity of 96–100%. On the other hand, the mentioned test 
describes a sensitivity and specificity of 100% for both IgM and IgG for chikungu-
nya’s diagnosis [44].
In the literature, there is the case of a dengue patient who developed Guillain-
Barre syndrome, who presented the NS1 antigen on the second day of symptoms 
with subsequent IgM and IgG positive on the sixth day of evolution [45]. There is 
also another case described with similar laboratory findings, but that developed 
the syndrome approximately 2 weeks after the onset of dengue symptoms [46]. 
Therefore, this syndrome could develop early or late in relation to the onset of 
symptoms due to infection. In our cases, we did not have positive IgM and we did 
not have the opportunity to evaluate the NS1 antigen, but it is noteworthy that all 
cases detected with flavivirus antibodies only had positive IgG in their results. The 
previous cases described in the existing literature may represent primary cases of 
dengue since they raised IgM values early.
In our cases, the majority of patients did not show joint pain during the diagnosis 
of Guillain-Barre syndrome, which could suggest that these are non-acute cases, 
but as described in the case cited, this syndrome may occur during convalescence 
of the dengue; on the other hand, in an endemic area such as Lambayeque-Peru, 
the presence of cases with secondary infection that usually have low IgM values 
and not even increase it (Figure 5) should not attract attention [47]. In addition, 
Ramabhatta et al. [48] conducted a study on a sample of 568 cases diagnosed of 
dengue and showed that IgG-positive patients were more prone to complications 
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than IgM-positive patients, therefore, the etiological association between dengue 
and Guillain-Barre syndrome in the Lambayeque region could not be ruled out.
5. Dengue lethality
5.1 Lethality in the context of Peru and Latin America
In 2014, according to WHO and Pan American Health Organization (PAHO), 
the average fatality rate for the Americas is 0.04%, being among the countries with 
the highest rate, followed by Dominican Republic with 1.54%, Peru with 0.12%, 
compared to Guatemala and Colombia that have 0.07% [49]. In Colombia and Peru, 
the most frequent serotype 2 prevailed, and in the Dominican Republic serotype 4 
prevailed [50].
Nationally, the Center for Epidemiology, Prevention and Control of Diseases 
of the Ministry of Health, reported in 2017, 76,093 cases of dengue in the country 
(3.03 times more cases in relation to 2016, and the largest number of cases reported 
in the last 5 years [9, 51] and 92 reports of deaths by dengue, the highest number 
reported in the last 10 years) (Figure 6).
About 43.6% came from Piura, 17.1% from Loreto, 9.9% from Madre de Dios, 
8.8% from Ucayali, 4.2% from San Martín, and the remaining 16.4% from other 
regions; all the age groups were affected, but with a greater proportion in people 
over 65 (37%) and young adults (21.7%) [9].
In the Piura Healthcare Network, 30 deaths associated with dengue virus 
were confirmed by laboratory, and occurred between epidemiological weeks 
Nos. 08 and 35, over 8 months; a similar panorama reported by the Lambayeque 
Healthcare Network, which reported the death of six dengue-associated patients, 
until epidemiological week No. 20 [13, 52]; although this information could be 
underestimated, because in many cases it is attributed to pneumonia, and actually 
the cases of dengue are not properly diagnosed, causing figures not approximate to 
reality [53].
Figure 6. 
Death toll and dengue lethality in Peru, 2008–2017. Source: Metaxenic disease surveillance system of the Center 
for Epidemiology, Disease Prevention and Control of the Ministry of Health (CDC-Perú).
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In the departments of the north coast of Peru, such as Piura and Lambayeque, 
there are several conditions that favor the presence of epidemics, rainfall, and 
flooding due to the occurrence of the Coastal El Niño phenomenon, population 
growth at risk (young People, Urban Marginal Neighborhoods, etc) that is associ-
ated with the non-existence of basic infrastructure, insufficient water supply 
that leads to temporary water storage, constant circulation of Aedes aegypti, high 
temperatures and humidity, and poor community empowerment in the integrated 
control of vector control. Also in the Peruvian jungle, such as Loreto, Madre de 
Dios, Ucayali, and San Martin, they have a high incidence of death and lethality 
due to their diverse climatic and sanitary conditions, in addition to their population 
growth [13].
In the Healthcare Network of Piura, 22,562 cases of dengue were notified, 88 of 
which were severe dengue and 30 died, with 1.3% of lethality in general and 34.1% 
of lethality of severe cases; in Lambayeque there were 1384 cases; 13 being cases of 
severe dengue and nine deaths due to dengue, which makes 9.4% lethality in general 
and 43.3% lethality of severe cases, showing differences with national figures [37] 
(Table 3).
Although serotypes 2 and 3 were isolated in 94% of the positive cases; in Piura 
and Lambayeque, it was serotype 3 that was isolated in 90% of the cases and in 
almost all the deceased cases.
5.2  Delays in the process of health care as a method to identify the causes of 
mortality
The “delays” proposed by Thaddeus et al. in 1993, considered as the time 
between the appearance of a complication and its appropriate treatment and 
Country Serotype N° dengue 
cases
N° severe 
cases
Deceased General 
lethality 
(×1000)
Severe cases 
lethality 
(×100)
South 
America
387,669 1476 318 0.8 21.5%
Argentina DEN 1,3 557 0 0 0.0 0.0%
Bolivia DEN 1,4 10,842 66 15 1.4 22.7%
Colombia DEN 1,2,3 26,279 286 15 0.6 5.2%
Chile DEN 1,3 10 0 0 0.0 0.0%
Ecuador — 11,387 18 4 0.4 22.2%
Brazil DEN 1,2,3,4 252,054 378 133 0.5 35.2%
Venezuela DEN 1 8615 359 16 1.9 4.5%
Paraguay DEN 1,2 1832 0 0 0.0 0.0%
Uruguay — 0 0 0 0.0 0.0%
Peru DEN 2,3 74,648 251 92 1.2 36.7%
Essalud Piura* DEN 2,3 22,562 88 30 1.3 34.1%
Essalud 
Lambayeque*
DEN 2,3 1384 30 13 9.4 43.3%
Taken and adapted: Díaz-Vélez et al. [37, 50].
Table 3. 
General lethality and severe cases lethality of dengue reported by Social Security of Piura and Lambayeque 
compared to countries of South America, 2017.
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resolution, initiating these concepts in the framework of care for severe maternal 
mortality and morbidity evaluating them as autonomy factors for the search for 
medical care, distance, and health services [36]. The use of this approach is consid-
ered, since it would allow to identify and classify the barriers and situations related 
to the search for medical care in patients affected by dengue, which are part of a 
chain of delays or delays that would hinder risk prevention, limit the access to qual-
ity health services, and would result in the lack of timely attention to the complica-
tion and, consequently, in death [54].
5.2.1 Delay in the recognition of the health problem
Poor recognition of a clinical disorder is one of the factors that cause the delay in 
seeking attention. It includes deficiencies in health education for communities and 
families, which makes it difficult to recognize warning signs (signs and symptoms) 
in conditions that can be life-threatening [36].
5.2.2 Delay in deciding to get attention
This delay is usually caused by limitations in the understanding of what 
medical care implies and could lead to a large number of patients arriving at 
health facilities in poor conditions, including factors such as information on 
dengue and institutional recognition, social and environmental situation, onset 
of symptoms, self-medication, gender and initial care, and motivations to make 
decisions [36, 55].
5.2.3 Delay in arriving at health services
It involves the difficulty of arriving at a health facility, either because of the dif-
ficult access to services or because it takes too long to reach the place of care, which 
can discourage the patient from seeking care, even when he has decided to seek 
care opportunely. It is generally the result of the lack of access to health services 
and economic, organizational, and sociocultural barriers which control the use of 
services. It is also possible to mention travel time, transport system used, and the 
socioeconomic impact of the delay [36, 55].
5.2.4 Delay in receiving the appropriate treatment
The cumulative effect of the first and second delays helps increase the risk of 
arrival at the health facility in serious conditions. Some never arrive at the hospital, 
and even if they do, it is possible that the treatment given to them is not adequate 
and poor surveillance or administrative procedures hinder the care. Other studies 
have shown more causes for inadequate treatment: chronic lack of trained personnel 
and essential supplies. Other factors mentioned are: failures in the operation of the 
public network, which determines waiting, reconsultation, and family movements 
between institutions; poor staff training and high emergency saturation [36, 55].
In relation to the first delay, aspects such as the delay in recognizing the health 
problem, absence of preventive-promotional talks, and lack of recognition of risk 
situations are described as the main ones, similar to studies that describe the popu-
lation ignorance about the possibility of disease severity [56]. This last point reflects 
the poor knowledge by the population of less frequent dengue symptoms that in 
turn are associated with severity [57]. In the second delay, there are cases that went 
to non-health personnel and even self-medicating that are associated with delay as 
an explanation of serious or fatal cases [55, 58, 59] (Figure 7).
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In the third delay, limitations for access to health services are evidenced, and 
some are given references, but lack of economic resources or available transporta-
tion is evidenced, thus also describing the distance of health facilities (to go to 
the nearest one) [60]. Finally, the fourth delay involves aspects such as the time 
of transfer to establishments of greater resolving capacity and the waiting time of 
cases upon arrival in emergencies, as mentioned by Ardila et al. [55], who describe 
the feeling of discomfort generated by a new interrogation and the waiting time 
that involves admission to a health facility of greater complexity (Figure 7).
6. Preventive measures against dengue
A study conducted in a population with a recent dengue outbreak showed that 
the level of knowledge was low in 76.2% of the population, 45% did not recognize 
the bite of the vector as the form of disease transmission, and 34% did not recog-
nize the etiologic agent; of the most recognized clinical manifestations were fever, 
followed by headache, and musculoskeletal pain. Overall, 74.9% have a low level of 
knowledge about warning signs and about 93% were intermediate/low in preven-
tion, and 43% of them are unaware of the reproduction of the vector, and 71% are 
unaware of the role of abate; results that show that the population despite having 
been exposed still does not know the prevention measures [61].
PAHO has planned to cooperate with member countries to stimulate the 
search for concrete solutions through a communication methodology to impact 
behavior (COMBI) [62, 63]. It should be noted that, since the introduction 
of dengue in America, attempts have been made to propose some integrated 
programs, with a community approach to the control of Aedes aegypti. This 
approach has been to educate the community about dengue disease and how to 
prevent transmission by controlling the Aedes aegypti vector in the domestic and 
Figure 7. 
Timeline of delays in the process of care of lethal cases care of dengue in two hospitals of EsSalud, in the 
Departments of Piura and Lambayeque, during 2017. Taken from: Burga-Cueva et al. Analysis of Lethality by 
Dengue in two Essalud Hospitals, in the Departments of Piura and Lambayeque. 2017. [64].
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community environments; in this context, it has been documented that many of 
these programs were successful in educating the community about dengue and 
its prevention [65].
Nevertheless, this improvement of the cognitive level related to the disease 
has not resulted in the action of preventing the disease. In this sense, even though 
people in a region with dengue endemicity are very well versed in the disease, they 
do not implement these measures that they know control vector proliferation and 
therefore the transmission of dengue; therefore, it is essential to reorient educa-
tional programs focused on the behavioral change of the population [66].
Likewise, historically in the region, efforts to control dengue vectors resulted in 
the elimination of populations of Aedes aegypti in many of the tropical and subtropical 
countries by the 1970s. However, vector populations were reintroduced through the 
emergence of new serotypes [67]. Therefore, currently, the main purpose of most 
programs is to reduce the densities of vector populations as much as possible and keep 
them at low levels. When feasible, efforts should also be made to reduce the longevity 
of adult female mosquitoes through the use of insecticidal methods in order to reduce 
the risk of virus transmission [65].
It should be noted that keeping infestation with A. aegypti low carries significant 
economic costs to society; however, when an outbreak of dengue occurs, the cost 
increases considerably in vector control and patient care; so, from this perspective, 
effectiveness and profitability could be maximized by intervening in the vector 
habitat (potential hatcheries) through promotion and prevention actions [68–70]. 
Although the concept of vector control is reasonable, control should be early in an 
outbreak or applied strategically during periods between epidemics to avoid escalation 
in transmission [71].
Another preventive measure to control the rapid spread of an outbreak is to 
manage the infected human host and prevent it from infecting Aedes mosquitoes, 
this in turn would reduce the amount of new infections to humans, breaking the 
epidemiological chain of dengue transmission [72]. So, meanwhile, there is no 
vaccine with proven efficacy for dengue prevention in all population groups, and 
the main strategy to prevent transmission and disease is vector control through the 
elimination of larval habitats (elimination of potential hatcheries) and prevention 
of mosquito-human contact [73]. Some well-documented successes indicate that 
rigorously applied vector control can reduce the transmission of DENV and the 
disease [74].
In that sense, success in reducing the burden of dengue on public health will 
require an integrated multiple approach; although the concept of integrated 
intervention for dengue prevention is gaining increasing acceptance, to date, no 
consensus has been reached regarding the details of how and what combination of 
approaches can be implemented most effectively to control the disease [75].
Integrated vector management, the strategic method promoted by WHO, is 
defined as, “a rational decision-making process for the optimal use of resources 
for vector control,” which includes lobbying, social mobilization, and legislation; 
planning and delegated decision-making at the lowest possible administrative 
level; guaranteeing the rational use of available resources; adaptation of strategies 
and interventions based on vector habitat, epidemiology, and local resources; and 
development of an essential infrastructure for integrated vector management based 
on the situation analysis [67].
However, the discipline of vector control has been strongly influenced by the 
theory developed by Ronald Ross and George Macdonald (i.e., the Ross-Macdonald 
model), which states that the potential for transmission of mosquito-borne patho-
gens depends largely on the abundance of adult vector mosquitoes, survival through 
the incubation period of the pathogen, and the rate of human infection [76].
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Therefore, with this approach, interventions that reduce the population density 
of adult mosquitoes, the daily probability of survival, and the contact of the mos-
quito with humans are expected to have the greatest impact on decreasing virus 
transmission. It should be noted, however, that the Ross-Macdonald model was 
not formulated to specifically explore larval mosquito control. Recent quantitative 
assessments indicate that, under certain circumstances, control of the larvae may 
lead to greater than expected reductions in the transmission of pathogens [77]. In the 
context of larval control of Aedes aegypti, there should be the large-scale elimination 
of potential hatcheries.
In this context, taking into account that there is limited efficacy and intensity 
of the interventions used for dengue vector control, other alternatives to combat 
dengue endemic persistence are explored. Sustainable community participation and 
school-based health education interventions have finally evolved as an effective tool in 
reducing the larval source over other interventions [78], since children have inherent 
curiosity and enthusiasm to learn new things. Therefore, they can serve as an effective 
change agent to achieve a change in behavior in the family and community.
Methods for vector control include elimination or management of larval habi-
tats, eliminating larvae with insecticides, the use of biological agents, and the appli-
cation of adulticides; being for our conviction the elimination and management of 
larval habitats. Habitats are eliminated by preventing the access of mosquitoes to 
these containers or by emptying and cleaning them frequently, eliminating the evo-
lutionary stages with the use of insecticides or biological control agents, eliminating 
adult mosquitoes with insecticides, or by combining these methods [79].
Habitat management seeks to change the environment in order to prevent or 
minimize the propagation of vectors and human contact with the vector pathogen, 
destroying, altering (proper conservation of disused material), and eliminating 
or recycling nonessential containers that serve as larval habitats. Efforts to reduce 
solid waste should be directed against disposable or nonessential containers [78].
However, the main method of Aedes control (and, generally, the only one) used 
in many countries, remains the spatial application of ultralow volume insecticides 
(ULVs) for the control of adult mosquitoes [63]. This strategy has to be repeated 
constantly, its cost is high, and its effectiveness is limited. Aedes aegypti prefers to 
stay inside the houses, therefore, the insecticide aerial application or from trucks 
simply does not reach the mosquitoes that stay in hidden places, such as wardrobes. 
There have been several cases of homeowners in various countries who have not 
allowed the entry of home spraying equipment or have closed windows and doors 
well to prevent outside fog produced by the insecticide from entering their homes, 
reducing in this way the effectiveness of the intervention [65] (Table 4).
Due to inadequate dengue surveillance systems, spraying does not arrive in time 
to prevent epidemic transmission, and adult mosquito populations return quickly 
after spraying. Public confidence and complacency regarding such an ineffective 
approach have only made the challenge of explaining the need for community 
participation in hatchery control greater [79].
Therefore, our approach, which is the most cost-effective measure to control the 
transmission of dengue, would be based on the design and execution of activities 
aimed at eradicating vector proliferation through the elimination of favorable habi-
tats (potential hatcheries: tires, bottles, and buckets) for oviposition and allowing the 
development of the aquatic stages of the vector; with a participatory methodology 
based on the sociocultural characteristics of the population under study, with the 
local schools as main actors; for which, at first, the level of knowledge, attitude, and 
practice of dengue prevention measures of the population must be determined and 
from which it will design and carry out promotional, prevention interventions, with 
emphasis on behavioral changes.
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Finally, the need for a good understanding and emphasis on behaviors related 
to the management of Aedes aegypti hatcheries, the main dengue vector; it should 
be the promotion and prevention approach at the community level, divided into 
individual and collective activities for the prevention of Aedes aegypti reproduction, 
prevention of exposure to Aedes mosquitoes, and seeking medical attention.
Taken from: Parks W, Lloyd L. COMBI. Planning social mobilization and com-
munication for the prevention and control of dengue. Ginebra; 2004 [65].
Aedes mosquito breeding 
prevention
Prevention of exposure 
to Aedes mosquito bites
Search for medical 
attention
Individuals and 
households
• Water storage practices
• Home plant care
• Animal care
• Garbage disposal
• Storage of daytime materi-
als in the yard
• Use of insecticides and 
spray repellents
• Placing wire mesh on 
windows and doors
• Sleep protected by a 
mosquito net during 
naps
• Disease 
recognition
• Home treatment
• Search for medical 
attention
Communities, 
community 
groups, schools, 
NGOs
• Communication with 
behavioral impact
• Community cleaning
• Promotion or organiza-
tion of essential services: 
water, garbage collection
• Promotion of the recycling 
of tires, cans, bottles, etc.
• Housing improvement • Facilitation of 
patient transport 
to health facilities
Table 4. 
Comprehensive behavioral monitoring of mobilization and social communication for dengue prevention and 
control.
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